Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
about
A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer.Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stagesCabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma.Cabozantinib for the treatment of kidney cancer.Cabozantinib for Renal Cell Carcinoma: Current and Future Paradigms.Investigational new drugs for brain cancer.Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma.A population pharmacokinetic model of cabozantinib in healthy volunteers and patients with various cancer types.Inhibiting TRK Proteins in Clinical Cancer Therapy.Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody
P2860
Q33434042-BAB59886-CB28-4CC5-B7AD-3FFD9BF19BFDQ33618760-3A2ACC78-1301-4653-B647-E238D1FC808DQ37672483-C80924AD-D1D8-40D8-972B-43F713ECECB5Q38668871-66384EB3-1BB8-4F92-8C49-455691F344E0Q38746778-48B7BDC5-A3F1-45FC-82FE-9B507116F9E6Q38832510-03C45A57-5FAF-40C7-8645-94D6ADED3784Q49953442-EB15E2E3-D046-49B9-9783-994A8BD29096Q52568014-A4B4821C-57D2-4C87-AEFB-6BA50F845831Q54117764-A07A89D1-1E5D-4706-8D36-2032C864EF32Q58748732-527AEEF2-D52B-49CF-B545-F8F63EF7F15C
P2860
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phase 1 dose escalation trial ...... ients with high-grade gliomas.
@ast
Phase 1 dose escalation trial ...... ients with high-grade gliomas.
@en
type
label
Phase 1 dose escalation trial ...... ients with high-grade gliomas.
@ast
Phase 1 dose escalation trial ...... ients with high-grade gliomas.
@en
prefLabel
Phase 1 dose escalation trial ...... ients with high-grade gliomas.
@ast
Phase 1 dose escalation trial ...... ients with high-grade gliomas.
@en
P2093
P2860
P921
P356
P1433
P1476
Phase 1 dose escalation trial ...... ients with high-grade gliomas.
@en
P2093
David Schiff
Marc C Chamberlain
Michael Glantz
Patrick Y Wen
Thomas Mikkelsen
Timothy Cloughesy
P2860
P304
P356
10.1002/CNCR.29798
P407
P577
2015-11-20T00:00:00Z